Structure and tailspike glycosidase machinery of ORF212 from E. coli O157:H7 phage CBA120 (TSP3).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 05 2019
Historique:
received: 11 02 2019
accepted: 30 04 2019
entrez: 16 5 2019
pubmed: 16 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

Bacteriophage tailspike proteins mediate virion absorption through reversible primary receptor binding, followed by lipopolysaccharide or exopolysaccharide degradation. The Escherichia coli O157:H7 bacteriophage CBA120 genome encodes four distinct tailspike proteins, annotated as ORFs 210 through 213. Previously, we reported the crystal structure of ORF210 (TSP1). Here we describe the crystal structure of ORF212 (TSP3) determined at 1.85 Å resolution. As observed with other tailspike proteins, TSP3 assembles into a trimer. Each subunit of TSP3 has an N-terminal head domain that is structurally similar to that of TSP1, consistent with their high amino acid sequence identity. In contrast, despite sharing a β-helix fold, the overall structure of the C-terminal catalytic domain of TSP3 is quite different when compared to TSP1. The TSP3 structure suggests that the glycosidase active site resides in a cleft at the interface between two adjacent subunits where three acidic residues, Glu362 and Asp383 on one subunit, and Asp426 on a second subunit, are located in close proximity. Comparing the glycosidase activity of wild-type TSP3 to various point mutants revealed that catalysis requires the carboxyl groups of Glu362 and Asp426, and not of Asp383, confirming the enzyme employs two carboxyl groups to degrade lippopolysaccharide using an acid/base mechanism.

Identifiants

pubmed: 31089181
doi: 10.1038/s41598-019-43748-9
pii: 10.1038/s41598-019-43748-9
pmc: PMC6517402
doi:

Substances chimiques

Viral Tail Proteins 0
Glycoside Hydrolases EC 3.2.1.-
tailspike protein, bacteriophage EC 3.2.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

7349

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM110202
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
ID : R01GM110202
Pays : International

Références

Mol Microbiol. 2008 Jul;69(2):303-16
pubmed: 18547389
Mol Microbiol. 2017 Aug;105(3):385-398
pubmed: 28513100
Infect Immun. 2007 Apr;75(4):1661-6
pubmed: 17158899
Arch Virol. 1998;143(10):2051-63
pubmed: 9856093
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Structure. 1993 Dec 15;1(4):241-51
pubmed: 8081738
Nat Struct Biol. 1995 Jun;2(6):472-9
pubmed: 7664110
Virol J. 2011 Sep 07;8:430
pubmed: 21899740
Appl Environ Microbiol. 2012 Jan;78(1):58-69
pubmed: 22020516
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Virology. 2012 May 10;426(2):93-9
pubmed: 22341309
Structure. 2008 May;16(5):766-75
pubmed: 18462681
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Arch Virol. 2018 Sep;163(9):2601-2631
pubmed: 29754305
J Biol Chem. 1989 Jun 25;264(18):10693-8
pubmed: 2525128
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
pubmed: 15299374
PLoS One. 2014 Mar 26;9(3):e93156
pubmed: 24671238
Curr Gastroenterol Rep. 2012 Aug;14(4):317-23
pubmed: 22610457
J Virol. 2008 Mar;82(5):2265-73
pubmed: 18077713
Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 2):1772-9
pubmed: 12351820
Acta Crystallogr D Biol Crystallogr. 2008 Jan;64(Pt 1):61-9
pubmed: 18094468
J Microbiol Biotechnol. 2010 Jan;20(1):5-14
pubmed: 20134227
Curr Opin Microbiol. 2005 Aug;8(4):451-8
pubmed: 16019256
J Mol Biol. 1997 Apr 11;267(4):865-80
pubmed: 9135118
Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66
pubmed: 16855301
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
pubmed: 12393927
Arch Virol. 2012 Oct;157(10):2035-46
pubmed: 22707043
Adv Exp Med Biol. 2012;726:143-79
pubmed: 22297513
Science. 1994 Jul 15;265(5170):383-6
pubmed: 8023158
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):271-81
pubmed: 21460445
J Synchrotron Radiat. 2004 Jan 1;11(Pt 1):53-5
pubmed: 14646133
J Bacteriol. 1995 Jul;177(14):4121-30
pubmed: 7608087

Auteurs

Julia Greenfield (J)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.
Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, USA.

Xiaoran Shang (X)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.

Heng Luo (H)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.

Yan Zhou (Y)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.

Ryan D Heselpoth (RD)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.

Daniel C Nelson (DC)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA. nelsond@umd.edu.
Department of Veterinary Medicine, University of Maryland, College Park, Maryland, USA. nelsond@umd.edu.

Osnat Herzberg (O)

Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA. osnat@umd.edu.
Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, USA. osnat@umd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH